Table 3.
Variable | Study Group | Control Group | p |
---|---|---|---|
VLDL (mmol/L) | 1.76 ± 0.50 | 1.67 ± 0.43 | 0.098 |
IDL-C (mmol/L) | 0.82 ± 0.28 | 0.82 ± 0.28 | 0.459 |
IDL-B (mmol/L) | 0.50 ± 0.19 | 0.54 ± 0.17 | 0.054 |
IDL-A (mmol/L) | 0.39 ± 0.18 | 0.46 ± 0.19 | 0.013 * |
LDL size (Å) | 273 ± 5 | 272 ± 5 | 0.104 |
LDL-1 and 2 (mmol/L) | 0.59 | 0.71 | 0.045 * |
LDL-3 to 7 (mmol/L) | 0.04 | 0.08 | 0.056 |
HDL-1 to 7 (mmol/L) | 1.09 | 1.14 | 0.185 |
HDL-8 to 10 (mmol/L) | 0.08 | 0.12 | 0.003 ** |
For simplification, a summary of the non-atherogenic (LDL-1 and 2 and HDL-1 to 7) and atherogenic fractions (LDL-3–7 and HDL-8–10) of LDL-C and HDL-C are listed. p, p value of a two-sample t-test assuming equal variances; * p < 0.050 ** p < 0.010.